BioNTech
BioNTech is a German company that develops immunotherapies for the treatment of cancer and other diseases.
9
Funding Rounds
$1.8b
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ch******* Hu*** | - | - | |
| Ug** Sa*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Mi***** Mo******** | - | - | |
| He**** Je**** | - | - | |
| Ch******* Hu*** | - | - | - |
| Ul**** Wa*********** | - | - |
Funding
Funding series
Funding Series Analysis
The company BioNTech has raised a total of $1.51b in funding over 9 rounds.
Key Insights:
- BioNTech Grant (money), September 15, 2020: $455.6m
- BioNTech Venture round, June 29, 2020: $250m
- BioNTech Venture round, December 17, 2019: $60.75m
- BioNTech Grant (money), September 4, 2019: $55m
- BioNTech Series B round, July 2019: $325m
- BioNTech Funding Round 2018: $91.5m
- BioNTech Series A round, January 2017: $270m
- BioNTech funding round, January 2018: $270m
BioNTech Grant (money), September 15, 2020
$455.6m
BioNTech Venture round, June 29, 2020
$250m
BioNTech Venture round, December 17, 2019
$60.75m
BioNTech Grant (money), September 4, 2019
$55m
BioNTech Series B round, July 2019
$325m
BioNTech Funding Round 2018
$91.5m
BioNTech Series A round, January 2017
$270m
BioNTech funding round, January 2018
$270m
Industries
BioNTech is active in the following industries:
- Cancer immunotherapy
- Vaccine
- Drug discovery
- Therapeutics
- Medical diagnostics
- Research and development
- Biomedical engineering
- Biopharmaceutical
- Immunotherapy
- Cancer
- Oncology
- Cell therapy
- Engineering
- Technology
- Biology
- Biotechnology
- RNA-based and RNA-targeted therapeutics
- Healthcare
- Internal medicine
- Regenerative medicine
- Medicine
- Synthetic chemistry
- CAR T-Cell therapy
